PL334241A1 - Leucotriene antagones against squamous epithelium carcinoma of oral cavity - Google Patents
Leucotriene antagones against squamous epithelium carcinoma of oral cavityInfo
- Publication number
- PL334241A1 PL334241A1 PL97334241A PL33424197A PL334241A1 PL 334241 A1 PL334241 A1 PL 334241A1 PL 97334241 A PL97334241 A PL 97334241A PL 33424197 A PL33424197 A PL 33424197A PL 334241 A1 PL334241 A1 PL 334241A1
- Authority
- PL
- Poland
- Prior art keywords
- antagones
- leucotriene
- oral cavity
- squamous epithelium
- epithelium carcinoma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3426996P | 1996-12-13 | 1996-12-13 | |
| US4087497P | 1997-03-21 | 1997-03-21 | |
| PCT/US1997/021953 WO1998025615A1 (en) | 1996-12-13 | 1997-12-02 | Leukotriene antagonists for oral squamous cell carcinoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL334241A1 true PL334241A1 (en) | 2000-02-14 |
Family
ID=26710754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL97334241A PL334241A1 (en) | 1996-12-13 | 1997-12-02 | Leucotriene antagones against squamous epithelium carcinoma of oral cavity |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0964683A4 (en) |
| JP (1) | JP2001509142A (en) |
| KR (1) | KR20000069452A (en) |
| CN (1) | CN1245429A (en) |
| AU (1) | AU726215B2 (en) |
| CA (1) | CA2274855A1 (en) |
| EA (1) | EA002742B1 (en) |
| IL (1) | IL130304A0 (en) |
| NO (1) | NO992846L (en) |
| NZ (1) | NZ335922A (en) |
| PL (1) | PL334241A1 (en) |
| TR (1) | TR199901307T2 (en) |
| UA (1) | UA47505C2 (en) |
| WO (1) | WO1998025615A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002009700A1 (en) | 2000-07-28 | 2002-02-07 | Cancer Research Technology Limited | Cancer treatment by combination therapy |
| GB0121285D0 (en) | 2001-09-03 | 2001-10-24 | Cancer Res Ventures Ltd | Anti-cancer combinations |
| GB2386836B (en) | 2002-03-22 | 2006-07-26 | Cancer Res Ventures Ltd | Anti-cancer combinations |
| GB2394658A (en) | 2002-11-01 | 2004-05-05 | Cancer Rec Tech Ltd | Oral anti-cancer composition |
| US8093253B2 (en) * | 2008-03-06 | 2012-01-10 | Hoffmann-La Roche Inc. | Leukotriene B4 inhibitors |
| KR101898879B1 (en) | 2014-03-05 | 2018-09-14 | 재단법인 진안홍삼연구소 | A composition comprising the red ginseng extract of postmanufacture for treating or preventing oral squamous cell carcinoma |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6372648A (en) * | 1986-09-16 | 1988-04-02 | Sumitomo Pharmaceut Co Ltd | Novel unsaturated fatty acid derivative |
| PH30449A (en) * | 1991-11-25 | 1997-05-28 | Lilly Co Eli | Substituted phenyl phenol leukotriene antagonists |
| CZ276694A3 (en) * | 1991-11-25 | 1995-11-15 | Lilly Co Eli | Process for preparing diphenyl derivative |
-
1997
- 1997-02-12 UA UA99063226A patent/UA47505C2/en unknown
- 1997-12-02 IL IL13030497A patent/IL130304A0/en unknown
- 1997-12-02 PL PL97334241A patent/PL334241A1/en unknown
- 1997-12-02 NZ NZ335922A patent/NZ335922A/en unknown
- 1997-12-02 CA CA002274855A patent/CA2274855A1/en not_active Abandoned
- 1997-12-02 AU AU78451/98A patent/AU726215B2/en not_active Ceased
- 1997-12-02 CN CN97181730A patent/CN1245429A/en active Pending
- 1997-12-02 EA EA199900543A patent/EA002742B1/en not_active IP Right Cessation
- 1997-12-02 EP EP97949709A patent/EP0964683A4/en not_active Withdrawn
- 1997-12-02 WO PCT/US1997/021953 patent/WO1998025615A1/en not_active Ceased
- 1997-12-02 KR KR1019997005275A patent/KR20000069452A/en not_active Ceased
- 1997-12-02 JP JP52676298A patent/JP2001509142A/en not_active Ceased
- 1997-12-02 TR TR1999/01307T patent/TR199901307T2/en unknown
-
1999
- 1999-06-11 NO NO992846A patent/NO992846L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL130304A0 (en) | 2000-06-01 |
| TR199901307T2 (en) | 1999-08-23 |
| UA47505C2 (en) | 2002-07-15 |
| NO992846D0 (en) | 1999-06-11 |
| KR20000069452A (en) | 2000-11-25 |
| CN1245429A (en) | 2000-02-23 |
| JP2001509142A (en) | 2001-07-10 |
| NZ335922A (en) | 2000-12-22 |
| EA002742B1 (en) | 2002-08-29 |
| WO1998025615A1 (en) | 1998-06-18 |
| AU7845198A (en) | 1998-07-03 |
| AU726215B2 (en) | 2000-11-02 |
| EA199900543A1 (en) | 2000-02-28 |
| EP0964683A1 (en) | 1999-12-22 |
| EP0964683A4 (en) | 2002-08-14 |
| NO992846L (en) | 1999-06-11 |
| CA2274855A1 (en) | 1998-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4721897A (en) | Tetrahydroisoquinoline derivatives | |
| AUPM329894A0 (en) | Face protector shade | |
| EP0880905A4 (en) | Cigarette | |
| GB2302048B (en) | Rotating nozzle | |
| PL334241A1 (en) | Leucotriene antagones against squamous epithelium carcinoma of oral cavity | |
| GB2319461B (en) | Safety spoon | |
| GB2318813B (en) | Cavity closer | |
| AU1230597A (en) | Denture cleaning | |
| AUPN980296A0 (en) | Strip casting | |
| AU1233597A (en) | Tetrahydroisoquinoline derivatives | |
| AU2166797A (en) | Slip casting | |
| GB9418028D0 (en) | Cavity arrangements | |
| AU5175898A (en) | End face mounted insert | |
| AU1232497A (en) | Denture cleansing | |
| GB2293043B (en) | Cavity arrangements | |
| AUPN935696A0 (en) | Strip casting | |
| GR3034355T3 (en) | End protector | |
| GB2314101B (en) | Cavity closer | |
| HUP9902048A3 (en) | Compositions and methods for improving the performance of long-wearing cosmetic products | |
| AU7716896A (en) | Earmuff | |
| CA74967S (en) | Plaque | |
| CA74883S (en) | Plaque | |
| AUPO958597A0 (en) | Face protector | |
| GB9615005D0 (en) | Smooth sparkler | |
| PL104541U1 (en) | Segmented stairs |